Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 1/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | CYP2A6 | P11509 | 3/20 | 0.31 |
| ▸ | CASP3 | P42574 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.30 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20850277 | 0.76 | PDK2 (0.46) | PDK2 | |
| SCHEMBL20850442 | 0.75 | — | — | |
| SCHEMBL20880949 | 0.74 | CASP3 (0.32) | CYP2A6CASP3 | |
| SCHEMBL20850099 | 0.72 | CASP3 (0.37) | PDK2SMN1; SMN2CASP3 | |
| SCHEMBL20850487 | 0.72 | CYP2A6 (0.32) | CYP2A6CASP3PDGFRBPDGFRA | |
| SCHEMBL50526 | 0.71 | CES1 (0.35) | CYP2A6 | |
| SCHEMBL20850249 | 0.69 | PDK2 (0.35) | PDK2CASP3 | |
| SCHEMBL17068313 | 0.66 | CES1 (0.33) | CYP2A6 | |
| SCHEMBL20850152 | 0.66 | JUN (0.32) | PDGFRBPDGFRA | |
| SCHEMBL22503337 | 0.62 | CES1 (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3466937-B1 | PHOTOELECTRIC CONVERSION ELEMENT, TWO-DIMENSIONAL SENSOR, IMAGE SENSOR AND IMAGING DEVICE | CANON KK (JP) | 2021-03-24 | — | — | EP | disclosed |
| US-10947212-B2 | Photoelectric conversion element, two-dimensional sensor, image sensor, and image pickup device | CANON KABUSHIKI KAISHA (JP) | 2021-03-16 | — | — | US | disclosed |
| US-20190092743-A1 | PHOTOELECTRIC CONVERSION ELEMENT, TWO-DIMENSIONAL SENSOR, IMAGE SENSOR, AND IMAGE PICKUP DEVICE | CANON KABUSHIKI KAISHA (JP) | 2019-03-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190092743-A1 | PHOTOELECTRIC CONVERSION ELEMENT, TWO-DIMENSIONAL SENSOR, IMAGE SENSOR, AND IMAGE PICKUP DEVICE | NR2E3, CRY2, GPR3 | PDK2 828/4885NPC1 3567/4885GAA 4435/4885 |
| US-10947212-B2 | Photoelectric conversion element, two-dimensional sensor, image sensor, and image pickup device | NR2E3, CRY2, GPR3 | PDK2 828/4885NPC1 3567/4885GAA 4435/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.